Stephan D. Thome

Oncology

200 1st St SW
Rochester, MN 55905

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Patterns of excess and cause-specific mortality in vulvar squamous cell carcinoma: a Surveillance, Epidemiology, and End Results program population-based study.

Patterns of excess and cause-specific mortality in vulvar squamous cell carcinoma: a Surveillance, Epidemiology, and End Results program population-based study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 02, 2026

Racial disparities in survival among patients with vulvar melanoma: A National Cancer Database analysis.

Racial disparities in survival among patients with vulvar melanoma: A National Cancer Database analysis.

Journal: Journal of the American Academy of Dermatology

Published: March 16, 2026

Clinicopathologic, molecular, and treatment features of metastatic and distantly recurrent extramammary Paget disease: Mayo clinic experience.

Clinicopathologic, molecular, and treatment features of metastatic and distantly recurrent extramammary Paget disease: Mayo clinic experience.

Journal: The oncologist

Published: February 20, 2026

CDX2 expression as a predictive and prognostic biomarker of 5-FU response in cancer of unknown primary.

CDX2 expression as a predictive and prognostic biomarker of 5-FU response in cancer of unknown primary.

Journal: ESMO open

Published: May 06, 2025

Topical Cannabidiol for Established Chemotherapy-Induced Neuropathy: A Pilot Randomized Placebo-Controlled Trial.

Topical Cannabidiol for Established Chemotherapy-Induced Neuropathy: A Pilot Randomized Placebo-Controlled Trial.

Journal: Cannabis and cannabinoid research

Published: July 17, 2024

Rose geranium in sesame oil nasal spray to improve nasal vestibulitis symptoms: a randomized controlled trial.

Rose geranium in sesame oil nasal spray to improve nasal vestibulitis symptoms: a randomized controlled trial.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: December 01, 2023

Advancing head and neck cancer management: Unveiling the diagnostic and therapeutic potentials of molecular profiling.

Advancing head and neck cancer management: Unveiling the diagnostic and therapeutic potentials of molecular profiling.

Journal: Head & neck

Published: November 09, 2023

Incidence of Brain Metastasis as First Event in Patients with Esophageal Carcinoma: a Report from Three Prospective Alliance Clinical Trials.

Incidence of Brain Metastasis as First Event in Patients with Esophageal Carcinoma: a Report from Three Prospective Alliance Clinical Trials.

Journal: Journal of gastrointestinal cancer

Published: September 28, 2022

A five arm natural history study of nasal vestibulitis.

A five arm natural history study of nasal vestibulitis.

Journal: Cancer medicine

Published: April 12, 2022

Natural history of nasal vestibulitis associated with paclitaxel, docetaxel, and other chemotherapy agents: a Minnesota Cancer Clinical Trials Network (MNCCTN) study.

Natural history of nasal vestibulitis associated with paclitaxel, docetaxel, and other chemotherapy agents: a Minnesota Cancer Clinical Trials Network (MNCCTN) study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: December 07, 2020

Venetoclax induced a complete response in a patient with immunoglobulin light chain amyloidosis plateaued on cyclophosphamide, bortezomib and dexamethasone.

Venetoclax induced a complete response in a patient with immunoglobulin light chain amyloidosis plateaued on cyclophosphamide, bortezomib and dexamethasone.

Journal: Haematologica

Published: January 21, 2018

Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group.

Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group.

Journal: Mayo Clinic proceedings

Published: February 22, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026